Live market news
Stocks
ETON

Eton Pharmaceuticals, Inc.

ETONStockUnited States

See in Charts

Latest news on ETONranked by Oyticker for market impact

65Impact
Positive28 Sept 2026 · 10:50 UTC · Global · Medium term
Eton Pharmaceuticals launches IMPAVIDO (miltefosine) in U.S. market
Eton Pharmaceuticals announced U.S. commercial availability of IMPAVIDO (miltefosine) capsules, a rare-disease treatment. The launch represents a key revenue inflection point for the company's commercial pipeline.
ETONPharmaceuticalsRare Diseases

SEC filings

What ETON filed

All its filings

5 Nov 2026
Quarterly report (opens the document on sec.gov)10-Q
5 Nov 2026
Results announced (opens the document on sec.gov)8-K
5 Nov 2026
Other event (opens the document on sec.gov)8-K
2 Nov 2026
Other event (opens the document on sec.gov)8-K
14 Oct 2026
Acquisition or sale completed (opens the document on sec.gov)8-K
Material agreement
28 Sept 2026
Other event (opens the document on sec.gov)8-K
13 Aug 2026
Quarterly report (opens the document on sec.gov)10-Q
13 Aug 2026
Results announced (opens the document on sec.gov)8-K
5 Aug 2026
Acquisition or sale completed (opens the document on sec.gov)8-K
Material agreement
4 Aug 2026
Executive or director change (opens the document on sec.gov)8-K
29 Jul 2026
Other event (opens the document on sec.gov)8-K
9 Jun 2026
Shareholder vote results (opens the document on sec.gov)8-K
19 May 2026
Acquisition or sale completed (opens the document on sec.gov)8-K
Material agreement
14 May 2026
Quarterly report (opens the document on sec.gov)10-Q
14 May 2026
Results announced (opens the document on sec.gov)8-K

From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.

Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.

Latest news on ETONranked by Oyticker for market impact

Eton Pharmaceuticals launches IMPAVIDO (miltefosine) in U.S. market

What ETON filed